Skip to main content

Table 1 Demographic data of the SAH patients and related control groups

From: Lectin complement pathway initiators after subarachnoid hemorrhage — an observational study

 

CSF control group

(n = 12)

CSF

(n = 63)

Plasma Control Group

(n = 12)

Plasma

(n = 50)

Age, mean years (SD)

69 (± 9)

59 (±11)

55 (±7)

61 (± 11)

Sex, n (%)

 Men

8 (66.7)

14 (22.2)

4 (33.3)

5 (10)

 Women

4 (33.3)

49 (77.8)

8 (66,7)

45 (90)

WFNS, n (%)

 1

8 (12.7)

 

17 (34.0)

 2

12 (19.0)

8 (16.0)

 3

4 (6.3)

5 (10.0)

 4

21 (33.3)

10 (20.0)

 5

18 (28.6)

10 (20.0)

Fisher score, n (%)

 1

0 (0)

 

0 (0)

 2

1 (1.6)

4 (8.0)

 3

48 (77.4)

37 (74.0)

 4

13 (21.0)

9 (18.0)

Definite DCI, n (%)

18 (28.6)

 

13 (26.0)

Definitely not DCI, n (%)

18 (28.6)

 

20 (40.0)

Days from ictus to DCI, mean (SD)

6.5 (±1.5)

 

7.2 (±2.2)

mRS, n (%)

 0–2

34 (54.0)

 

35 (70.0)

 3–6 (poor functional outcome)

29 (46.0)

15 (30.0)

Aneurysm location, n (%)

 Anterior cerebral artery

25 (39.7)

 

16 (32.0)

 Middle cerebral artery

13 (20.6)

10 (20.0)

 Posterior cerebral artery

16 (25.4)

18 (36.0

 Internal carotid artery

9 (14.3)

6 (12.0)

Technique for securing aneurysm, n (%)

 Coil

42 (66.7)

 

35 (71.4

 Clip

21 (33.3)

14 (28.6)

Vasospasm, n (%)

 Yes

28 (73.7)

 

17 (70.8)

 No

10 (26.3)

7 (29.2)

  1. CSF cerebrospinal fluid, WFNS World Federation of Neurological Surgeons scale, EBI early brain injury, DCI delayed cerebral ischemia, mRS Modified ranking scale